Dalan Bailey

This study isolates and characterizes monoclonal antibodies against Nipah virus from an mRNA-immunized pig, showing their neutralizing activity and potential for therapeutic use.

This study investigates the phenotypic effects of naturally occurring MERS-CoV Spike mutations on virus entry and neutralisation, identifying mutations that enhance entry or confer resistance to neutralisation.

This study identifies cross-neutralizing mAbs against diverse bat sarbecoviruses and characterizes their conserved epitopes for vaccine design.

This study examines the host range and antigenicity of bat sarbecoviruses, finding that generalist ACE2 users are more related to SARS-CoV-2 and show broader cross-neutralization.

This paper develops a bispecific antibody that targets both Nipah virus surface glycoproteins, reducing viral escape and enhancing protection against NiV disease.

This study identifies molecular genotypes and key residues that determine receptor tropism in alphacoronaviruses, revealing generalist and specialist host ranges and potential spillover routes.

The paper analyzes antibody neutralization data from multiple countries to assess how prior exposure to SARS-CoV-2 variants affects neutralization profiles of BA.2.86 and its descendants.

This study shows that hypoxia inducible factors (HIFs) suppress RSV infection by reducing nucleolin expression and inhibiting viral replication and inflammation.

The paper screens bat samples for coronaviruses, identifies novel strains, and assesses their potential to infect humans.

This study identifies HVR-1 as an autoinhibitory region in HCV E1E2 that suppresses viral entry through conformational entropy, which is released upon receptor binding to enhance entry but reduce antibody resistance.

This paper shows that viral infection increases vomocytosis of Cryptococcus neoformans by macrophages through type-I interferons.